CALL - SPRINTER OPEN END - EDWARDS LIFESCIENCES | Delayed Deutsche Boerse AG 10:53:41 2024-07-17 am EDT | ||
| 2.23 EUR | -1.33% |
|
| Current month | -20.70% | ||
| 1 month | -2.59% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-07-17 | 2.23 | -1.33% |
| 24-07-16 | 2.26 | -5.83% |
| 24-07-15 | 2.4 | -10.78% |
| 24-07-12 | 2.69 | -6.60% |
| 24-07-11 | 2.88 | +0.35% |
Delayed Quote Deutsche Boerse AG
Last update July 17, 2024 at 10:53 am EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Vontobel
|
| WKN | VM55HF |
| ISIN | DE000VM55HF4 |
| Date issued | 2023-11-29 |
| Strike | 63.17 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.72 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.19 € |
|---|---|
| Lowest since issue | 0.66 € |
| Spread | 0.01 € |
| Spread % | 0.45% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
87.73
USD
Average target price
96.46
USD
Spread / Average Target
+9.95%
- Stock Market
- Certificates
- Certificat
